Dihexa in Clinical Trials: What We've Learned So Far DIHEXA is a neurogenic peptide designed to enhance cognitive function by increasing synaptic density in the brain. Unlike stimulants that offer temporary boosts, Dihexa supports long term brain health improving communication between Dissociating the Link of Neural Correlates of Inhibition to the Degree of Substance Use and Substance Related Problems: A Preregistered, Multimodal, Combined Cross sectional and Longitudinal Study Biological Psychiatry FDA Approves Expanded Use of PKU Medicine for Adolescents BioMarin Pharmaceutical Inc. posted on the topic LinkedIn The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet delivered cognitive behavioral therapy in the treatment of post traumatic stress disorder: a randomized, placebo controlled clinical trial